Annual low-dose CT screening has been recently shown to result in high cure rates of over 80%, but methods of conducting a lung cancer screening program vary and best practices have yet to emerge. To ...
A risk score built from 31 small RNA molecules found in blood was linked to lung cancer up to 10 years before diagnosis in a ...
Expanding the eligibility criteria for low-dose CT (LDCT) screening for lung cancer can increase the number of women and Black persons who can benefit from screening, according to a study published in ...
The overdiagonsis identified in the current study also led to overtreatment in this population, authors found. Low-dose CT (LDCT) screening of mostly nonsmoking Asian women was associated with ...
Family physicians lack sufficient knowledge about recommendations for low-dose computed tomography (LDCT) screening among patients at high risk for lung cancer, according to a small survey of South ...
In summary, the published literature on the use of LDCT to screen for lung cancer in high risk populations is promising, but not conclusive. None of the studies – even the most recent, large, ...
A study presented today by researchers with the Ministry of Health and Welfare in Taiwan confirmed the effectiveness of low-dose computed tomography (LDCT) screening in a pre-defined, never-smoker, ...
Certain patients can now receive Medicare coverage for lung cancer screening with low-dose computed tomography (LDCT), after CMS issued a national coverage determination (NCD) on February 5, 2015. 1 ...
Lung cancer is the most deadly form of cancer, responsible for 1.3 million deaths worldwide each year. Almost 400,000 Americans have the disease and about half will likely die within one year of ...
Austin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Lung Cancer Screening Market Size & Growth Analysis: According to SNS Insider, The Lung Cancer Screening Market was estimated at USD 3.66 billion in 2024 and ...
WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples ...